Impact of the malaria comprehensive case management programme in Odisha, India.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 20 09 2021
accepted: 28 02 2022
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 4 5 2022
Statut: epublish

Résumé

The Comprehensive Case Management Project (CCMP), was a collaborative implementation research initiative to strengthen malaria early detection and complete treatment in Odisha State, India. A two-arm quasi-experimental design was deployed across four districts in Odisha, representing a range of malaria endemicity: Bolangir (low), Dhenkanal (moderate), Angul (high), and Kandhamal (hyper). In each district, a control block received routine malaria control measures, whereas a CCMP block received a range of interventions to intensify surveillance, diagnosis, and case management. Impact was evaluated by difference-in-difference (DID) analysis and interrupted time-series (ITS) analysis of monthly blood examination rate (MBER) and monthly parasite index (MPI) over three phases: phase 1 pre-CCMP (2009-2012) phase 2 CCMP intervention (2013-2015), and phase 3 post-CCMP (2016-2017). During CCMP implementation, adjusting for control blocks, DID and ITS analysis indicated a 25% increase in MBER and a 96% increase in MPI, followed by a -47% decline in MPI post-CCMP, though MBER was maintained. Level changes in MPI between phases 1 and 2 were most marked in Dhenkanal and Angul with increases of 976% and 287%, respectively, but declines in Bolangir (-57%) and Kandhamal (-22%). Between phase 2 and phase 3, despite the MBER remaining relatively constant, substantial decreases in MPI were observed in Dhenkanal (-78%), and Angul (-59%), with a more modest decline in Bolangir (-13%), and an increase in Kandhamal (14%). Overall, CCMP improved malaria early detection and treatment through the enhancement of the existing network of malaria services which positively impacted case incidence in three districts. In Kandhamal, which is hyperendemic, the impact was not evident. However, in Dhenkanal and Angul, areas of moderate-to-high malaria endemicity, CCMP interventions precipitated a dramatic increase in case detection and a subsequent decline in malaria incidence, particularly in previously difficult-to-reach communities.

Sections du résumé

BACKGROUND
The Comprehensive Case Management Project (CCMP), was a collaborative implementation research initiative to strengthen malaria early detection and complete treatment in Odisha State, India.
METHODS
A two-arm quasi-experimental design was deployed across four districts in Odisha, representing a range of malaria endemicity: Bolangir (low), Dhenkanal (moderate), Angul (high), and Kandhamal (hyper). In each district, a control block received routine malaria control measures, whereas a CCMP block received a range of interventions to intensify surveillance, diagnosis, and case management. Impact was evaluated by difference-in-difference (DID) analysis and interrupted time-series (ITS) analysis of monthly blood examination rate (MBER) and monthly parasite index (MPI) over three phases: phase 1 pre-CCMP (2009-2012) phase 2 CCMP intervention (2013-2015), and phase 3 post-CCMP (2016-2017).
RESULTS
During CCMP implementation, adjusting for control blocks, DID and ITS analysis indicated a 25% increase in MBER and a 96% increase in MPI, followed by a -47% decline in MPI post-CCMP, though MBER was maintained. Level changes in MPI between phases 1 and 2 were most marked in Dhenkanal and Angul with increases of 976% and 287%, respectively, but declines in Bolangir (-57%) and Kandhamal (-22%). Between phase 2 and phase 3, despite the MBER remaining relatively constant, substantial decreases in MPI were observed in Dhenkanal (-78%), and Angul (-59%), with a more modest decline in Bolangir (-13%), and an increase in Kandhamal (14%).
CONCLUSIONS
Overall, CCMP improved malaria early detection and treatment through the enhancement of the existing network of malaria services which positively impacted case incidence in three districts. In Kandhamal, which is hyperendemic, the impact was not evident. However, in Dhenkanal and Angul, areas of moderate-to-high malaria endemicity, CCMP interventions precipitated a dramatic increase in case detection and a subsequent decline in malaria incidence, particularly in previously difficult-to-reach communities.

Identifiants

pubmed: 35324920
doi: 10.1371/journal.pone.0265352
pii: PONE-D-21-30361
pmc: PMC8947122
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0265352

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2016 Feb 11;11(2):e0149126
pubmed: 26866696
PLoS One. 2019 Sep 6;14(9):e0221223
pubmed: 31490940
PLoS Med. 2016 Apr 12;13(4):e1001993
pubmed: 27071072
Rev Soc Bras Med Trop. 2020 Sep 23;53:e20200048
pubmed: 32997048
Am J Trop Med Hyg. 2020 Oct;103(4):1510-1516
pubmed: 32783792
Malar J. 2020 Aug 14;19(1):292
pubmed: 32799857
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):108-120
pubmed: 27708188
J Vector Borne Dis. 2019 Jan-Mar;56(1):53-55
pubmed: 31070166
Glob Health Sci Pract. 2021 Mar 16;9(Suppl 1):S98-S110
pubmed: 33727323
Trop Med Int Health. 2015 Nov;20(11):1438-1446
pubmed: 26171642
J Vector Borne Dis. 2019 Jan-Mar;56(1):56-59
pubmed: 31070167
Malar J. 2016 Jul 15;15:363
pubmed: 27421656
Malar J. 2019 Feb 22;18(1):50
pubmed: 30795764
Malar J. 2016 Sep 22;15(1):488
pubmed: 27659770
PLoS Med. 2017 Nov 30;14(11):e1002453
pubmed: 29190295
Malar J. 2021 Mar 8;20(1):139
pubmed: 33685454
PLoS One. 2019 Jan 2;14(1):e0208943
pubmed: 30601833
Indian J Med Res. 2014 Feb;139(2):205-15
pubmed: 24718394
Malar J. 2021 Feb 16;20(1):98
pubmed: 33593368
Malar J. 2015 May 20;14:211
pubmed: 25985992
Int J Technol Assess Health Care. 2003 Fall;19(4):613-23
pubmed: 15095767
Malar J. 2020 Nov 16;19(1):410
pubmed: 33198754
Indian J Med Res. 2015 Dec;142 Suppl:S71-8
pubmed: 26905246
Malar J. 2019 Aug 22;18(1):279
pubmed: 31438943
PLoS Med. 2017 Nov 30;14(11):e1002456
pubmed: 29190300
Infect Dis Poverty. 2020 Feb 10;9(1):18
pubmed: 32036792
Sci Rep. 2019 Nov 19;9(1):17095
pubmed: 31745160
PLoS One. 2020 Sep 8;15(9):e0238323
pubmed: 32898853
PLoS Med. 2020 Aug 14;17(8):e1003227
pubmed: 32797101
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33380414
Trans R Soc Trop Med Hyg. 2021 Nov 1;115(11):1229-1233
pubmed: 34563095
PLoS Med. 2017 Nov 30;14(11):e1002452
pubmed: 29190279
Malar J. 2020 Apr 15;19(1):151
pubmed: 32293452
Malar J. 2013 Jan 03;12:4
pubmed: 23286228
Malar J. 2020 Sep 17;19(1):339
pubmed: 32943065

Auteurs

Madan M Pradhan (MM)

National Vector Borne Disease Control Programme, Government of Odisha, Bhubaneswar, India.

Sreya Pradhan (S)

National Vector Borne Disease Control Programme, Government of Odisha, Bhubaneswar, India.

Ambarish Dutta (A)

Indian Institute of Public Health, Bhubaneswar, India.
Kalinga Institute of Industrial Technology, Deemed to be University, Bhubaneswar, India.

Naman K Shah (NK)

University of North Carolina, Chapel Hill, North Carolina, United States of America.

Neena Valecha (N)

National Institute of Malaria Research, New Delhi, India.

Pyare L Joshi (PL)

Independent Malariologist, Gallup, Washington, D.C., United States of America.

Khageshwar Pradhan (K)

National Institute of Malaria Research Field Unit, Rourkela, India.

Penny Grewal Daumerie (P)

Medicines for Malaria Venture, Geneva, Switzerland.

Jaya Banerji (J)

Medicines for Malaria Venture, Geneva, Switzerland.

Stephan Duparc (S)

Medicines for Malaria Venture, Geneva, Switzerland.

Kamini Mendis (K)

Independent Malariologist, Colombo, Sri Lanka.

Surya K Sharma (SK)

National Institute of Malaria Research, New Delhi, India.

Shiva Murugasampillay (S)

Global Public Health, Geneva, Switzerland.

Anupkumar R Anvikar (AR)

National Institute of Malaria Research, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH